{"transactions":[{"id":812422,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":53238,"kind":"person","name":"Ajjarapu J. Ram","position":1,"cik":"0001423603","reported_name":"Ajjarapu J. Ram","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-08T21:47:11.000Z","date":"2026-03-16","kind":"purchase","planned":false,"acquired":true,"shares":689656,"price":0.29,"value":200000.24,"ownership":{"direct":false,"nature":"By International Capital Partners LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein."}],"balance_after":689656,"source":{"system":"sec-edgar","filing":"0001193125-26-148078","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423603/000119312526148078/ownership.xml","form_type":"4"}},{"id":1371684,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86226,"kind":"person","name":"Bracken-Ferguson Kendra","position":1,"cik":"0002033273","reported_name":"Bracken-Ferguson Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-08T17:13:51.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":378705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":378705,"derivative":{"exercise_price":0.358,"exercise_date":"2025-10-11","expiration_date":"2034-10-11","underlying":"Common Stock","underlying_shares":378705},"source":{"system":"sec-edgar","filing":"0000950170-24-124240","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033273/000095017024124240/ownership.xml","form_type":"4"}},{"id":1371652,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86225,"kind":"person","name":"Cassaday Bryan J.","position":1,"cik":"0002002588","reported_name":"Cassaday Bryan J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-08T17:00:12.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":120000,"derivative":{"exercise_price":0.358,"exercise_date":"2025-10-11","expiration_date":"2034-10-11","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000950170-24-124220","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2002588/000095017024124220/ownership.xml","form_type":"4"}},{"id":1371649,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86223,"kind":"person","name":"Spenlehauer Gilles","position":1,"cik":"0001997250","reported_name":"Spenlehauer Gilles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-08T17:00:10.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":76878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":76878,"derivative":{"exercise_price":0.358,"exercise_date":"2025-10-11","expiration_date":"2034-10-11","underlying":"Common Stock","underlying_shares":76878},"source":{"system":"sec-edgar","filing":"0000950170-24-124219","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1997250/000095017024124219/ownership.xml","form_type":"4"}},{"id":1370770,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-08T17:00:08.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":76878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":76878,"derivative":{"exercise_price":0.358,"exercise_date":"2025-10-11","expiration_date":"2034-10-11","underlying":"Common Stock","underlying_shares":76878},"source":{"system":"sec-edgar","filing":"0000950170-24-124218","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017024124218/ownership.xml","form_type":"4"}},{"id":1371061,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-08T17:00:06.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":76878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":76878,"derivative":{"exercise_price":0.358,"exercise_date":"2025-10-11","expiration_date":"2034-10-11","underlying":"Common Stock","underlying_shares":76878},"source":{"system":"sec-edgar","filing":"0000950170-24-124217","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017024124217/ownership.xml","form_type":"4"}},{"id":1370776,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-08T17:00:05.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":76878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":76878,"derivative":{"exercise_price":0.358,"exercise_date":"2025-10-11","expiration_date":"2034-10-11","underlying":"Common Stock","underlying_shares":76878},"source":{"system":"sec-edgar","filing":"0000950170-24-124216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017024124216/ownership.xml","form_type":"4"}},{"id":1371651,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86224,"kind":"person","name":"Frisch Scott M.","position":1,"cik":"0001997294","reported_name":"Frisch Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-08T17:00:03.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":76878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":76878,"derivative":{"exercise_price":0.358,"exercise_date":"2025-10-11","expiration_date":"2034-10-11","underlying":"Common Stock","underlying_shares":76878},"source":{"system":"sec-edgar","filing":"0000950170-24-124214","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1997294/000095017024124214/ownership.xml","form_type":"4"}},{"id":1370792,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-08T17:00:03.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":876878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":876878,"derivative":{"exercise_price":0.358,"exercise_date":"2025-10-11","expiration_date":"2034-10-11","underlying":"Common Stock","underlying_shares":876878},"source":{"system":"sec-edgar","filing":"0000950170-24-124215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024124215/ownership.xml","form_type":"4"}},{"id":1406449,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-16T16:30:07.000Z","date":"2024-09-13","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.4672,"value":2336.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $0.458 to $0.480, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000950170-24-106857","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017024106857/ownership.xml","form_type":"4"}},{"id":1410569,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-10T16:30:16.000Z","date":"2024-09-06","kind":"purchase","planned":false,"acquired":true,"shares":1260,"price":0.51,"value":642.6,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0000950170-24-105169","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017024105169/ownership.xml","form_type":"4"}},{"id":1410563,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-10T16:30:14.000Z","date":"2024-09-06","kind":"purchase","planned":false,"acquired":true,"shares":1261,"price":0.51,"value":643.11,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":18051,"source":{"system":"sec-edgar","filing":"0000950170-24-105168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017024105168/ownership.xml","form_type":"4"}},{"id":1411025,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86225,"kind":"person","name":"Cassaday Bryan J.","position":1,"cik":"0002002588","reported_name":"Cassaday Bryan J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-10T16:30:13.000Z","date":"2024-09-10","kind":"purchase","planned":false,"acquired":true,"shares":475,"price":0.46,"value":218.5,"ownership":{"direct":true},"balance_after":4250,"source":{"system":"sec-edgar","filing":"0000950170-24-105166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2002588/000095017024105166/ownership.xml","form_type":"4"}},{"id":1411024,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86224,"kind":"person","name":"Frisch Scott M.","position":1,"cik":"0001997294","reported_name":"Frisch Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-10T16:30:11.000Z","date":"2024-09-06","kind":"purchase","planned":false,"acquired":true,"shares":1009,"price":0.51,"value":514.59,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":7598,"source":{"system":"sec-edgar","filing":"0000950170-24-105167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997294/000095017024105167/ownership.xml","form_type":"4"}},{"id":1411023,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86223,"kind":"person","name":"Spenlehauer Gilles","position":1,"cik":"0001997250","reported_name":"Spenlehauer Gilles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-10T16:30:09.000Z","date":"2024-09-06","kind":"purchase","planned":false,"acquired":true,"shares":1009,"price":0.51,"value":514.59,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":7598,"source":{"system":"sec-edgar","filing":"0000950170-24-105170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997250/000095017024105170/ownership.xml","form_type":"4"}},{"id":1415097,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-04T18:26:20.000Z","date":"2024-08-30","kind":"purchase","planned":false,"acquired":true,"shares":109,"price":0.57,"value":62.13,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":21240,"source":{"system":"sec-edgar","filing":"0000950170-24-103547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017024103547/ownership.xml","form_type":"4"}},{"id":1416143,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86224,"kind":"person","name":"Frisch Scott M.","position":1,"cik":"0001997294","reported_name":"Frisch Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-04T16:51:33.000Z","date":"2024-08-30","kind":"purchase","planned":false,"acquired":true,"shares":87,"price":0.57,"value":49.59,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":6589,"source":{"system":"sec-edgar","filing":"0000950170-24-103471","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997294/000095017024103471/ownership.xml","form_type":"4"}},{"id":1415025,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-04T16:39:59.000Z","date":"2024-08-30","kind":"purchase","planned":false,"acquired":true,"shares":109,"price":0.57,"value":62.13,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":16790,"source":{"system":"sec-edgar","filing":"0000950170-24-103449","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017024103449/ownership.xml","form_type":"4"}},{"id":1416139,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86223,"kind":"person","name":"Spenlehauer Gilles","position":1,"cik":"0001997250","reported_name":"Spenlehauer Gilles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-04T16:34:52.000Z","date":"2024-08-30","kind":"purchase","planned":false,"acquired":true,"shares":87,"price":0.57,"value":49.59,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":6589,"source":{"system":"sec-edgar","filing":"0000950170-24-103448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997250/000095017024103448/ownership.xml","form_type":"4"}},{"id":1418724,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:08.000Z","date":"2024-08-29","kind":"purchase","planned":false,"acquired":true,"shares":652,"price":0.56,"value":365.12,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":16681,"source":{"system":"sec-edgar","filing":"0000950170-24-102374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017024102374/ownership.xml","form_type":"4"}},{"id":1418723,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:08.000Z","date":"2024-08-28","kind":"purchase","planned":false,"acquired":true,"shares":970,"price":0.56,"value":543.2,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":16029,"source":{"system":"sec-edgar","filing":"0000950170-24-102374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017024102374/ownership.xml","form_type":"4"}},{"id":1419099,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86224,"kind":"person","name":"Frisch Scott M.","position":1,"cik":"0001997294","reported_name":"Frisch Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:07.000Z","date":"2024-08-29","kind":"purchase","planned":false,"acquired":true,"shares":522,"price":0.56,"value":292.32,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":6502,"source":{"system":"sec-edgar","filing":"0000950170-24-102371","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1997294/000095017024102371/ownership.xml","form_type":"4"}},{"id":1419098,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86224,"kind":"person","name":"Frisch Scott M.","position":1,"cik":"0001997294","reported_name":"Frisch Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:07.000Z","date":"2024-08-28","kind":"purchase","planned":false,"acquired":true,"shares":599,"price":0.56,"value":335.44,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5980,"source":{"system":"sec-edgar","filing":"0000950170-24-102371","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997294/000095017024102371/ownership.xml","form_type":"4"}},{"id":1418754,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:06.000Z","date":"2024-08-29","kind":"purchase","planned":false,"acquired":true,"shares":652,"price":0.56,"value":365.12,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":21131,"source":{"system":"sec-edgar","filing":"0000950170-24-102373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017024102373/ownership.xml","form_type":"4"}},{"id":1418753,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:06.000Z","date":"2024-08-28","kind":"purchase","planned":false,"acquired":true,"shares":1084,"price":0.56,"value":607.04,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":20479,"source":{"system":"sec-edgar","filing":"0000950170-24-102373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017024102373/ownership.xml","form_type":"4"}},{"id":1419100,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86225,"kind":"person","name":"Cassaday Bryan J.","position":1,"cik":"0002002588","reported_name":"Cassaday Bryan J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-30T16:30:05.000Z","date":"2024-08-29","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.57,"value":570.0,"ownership":{"direct":true},"balance_after":3775,"source":{"system":"sec-edgar","filing":"0000950170-24-102370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2002588/000095017024102370/ownership.xml","form_type":"4"}},{"id":1418865,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:04.000Z","date":"2024-08-29","kind":"purchase","planned":false,"acquired":true,"shares":652,"price":0.56,"value":365.12,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":8128,"source":{"system":"sec-edgar","filing":"0000950170-24-102369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017024102369/ownership.xml","form_type":"4"}},{"id":1418864,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:04.000Z","date":"2024-08-28","kind":"purchase","planned":false,"acquired":true,"shares":749,"price":0.56,"value":419.44,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":7476,"source":{"system":"sec-edgar","filing":"0000950170-24-102369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017024102369/ownership.xml","form_type":"4"}},{"id":1419097,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86223,"kind":"person","name":"Spenlehauer Gilles","position":1,"cik":"0001997250","reported_name":"Spenlehauer Gilles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:03.000Z","date":"2024-08-29","kind":"purchase","planned":false,"acquired":true,"shares":522,"price":0.56,"value":292.32,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":6502,"source":{"system":"sec-edgar","filing":"0000950170-24-102372","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1997250/000095017024102372/ownership.xml","form_type":"4"}},{"id":1419096,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86223,"kind":"person","name":"Spenlehauer Gilles","position":1,"cik":"0001997250","reported_name":"Spenlehauer Gilles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:03.000Z","date":"2024-08-28","kind":"purchase","planned":false,"acquired":true,"shares":599,"price":0.56,"value":335.44,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5980,"source":{"system":"sec-edgar","filing":"0000950170-24-102372","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997250/000095017024102372/ownership.xml","form_type":"4"}},{"id":1419674,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-29T17:19:01.000Z","date":"2024-08-27","kind":"purchase","planned":false,"acquired":true,"shares":2413,"price":0.71,"value":1713.23,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":19395,"source":{"system":"sec-edgar","filing":"0000950170-24-101949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017024101949/ownership.xml","form_type":"4"}},{"id":1419626,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-29T17:17:20.000Z","date":"2024-08-27","kind":"purchase","planned":false,"acquired":true,"shares":1587,"price":0.71,"value":1126.77,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":15059,"source":{"system":"sec-edgar","filing":"0000950170-24-101944","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017024101944/ownership.xml","form_type":"4"}},{"id":1422920,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T19:59:49.000Z","date":"2024-08-26","kind":"purchase","planned":false,"acquired":true,"shares":1587,"price":0.72,"value":1142.64,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":13472,"source":{"system":"sec-edgar","filing":"0000950170-24-100725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017024100725/ownership.xml","form_type":"4"}},{"id":1422919,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T19:59:49.000Z","date":"2024-08-23","kind":"purchase","planned":false,"acquired":true,"shares":1587,"price":0.72,"value":1142.64,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":11885,"source":{"system":"sec-edgar","filing":"0000950170-24-100725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017024100725/ownership.xml","form_type":"4"}},{"id":1422944,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T19:58:38.000Z","date":"2024-08-26","kind":"purchase","planned":false,"acquired":true,"shares":2413,"price":0.72,"value":1737.36,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":16981,"source":{"system":"sec-edgar","filing":"0000950170-24-100723","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017024100723/ownership.xml","form_type":"4"}},{"id":1422943,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T19:58:38.000Z","date":"2024-08-23","kind":"purchase","planned":false,"acquired":true,"shares":2413,"price":0.72,"value":1737.36,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":14568,"source":{"system":"sec-edgar","filing":"0000950170-24-100723","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017024100723/ownership.xml","form_type":"4"}},{"id":1423966,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-23T17:25:43.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":1587,"price":0.72,"value":1142.64,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":10298,"source":{"system":"sec-edgar","filing":"0000950170-24-100267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017024100267/ownership.xml","form_type":"4"}},{"id":1423965,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-23T17:25:43.000Z","date":"2024-08-21","kind":"purchase","planned":false,"acquired":true,"shares":1984,"price":0.0792,"value":157.1328,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":8711,"source":{"system":"sec-edgar","filing":"0000950170-24-100267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017024100267/ownership.xml","form_type":"4"}},{"id":1423975,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-23T17:08:08.000Z","date":"2024-08-22","kind":"purchase","planned":false,"acquired":true,"shares":2413,"price":0.72,"value":1737.36,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":12156,"source":{"system":"sec-edgar","filing":"0000950170-24-100251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017024100251/ownership.xml","form_type":"4"}},{"id":1423974,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-23T17:08:08.000Z","date":"2024-08-21","kind":"purchase","planned":false,"acquired":true,"shares":3016,"price":0.792,"value":2388.672,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":9743,"source":{"system":"sec-edgar","filing":"0000950170-24-100251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017024100251/ownership.xml","form_type":"4"}},{"id":1426364,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-21T17:57:26.000Z","date":"2024-08-20","kind":"purchase","planned":false,"acquired":true,"shares":3600,"price":0.894,"value":3218.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $0.889 to $0.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000950170-24-099586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017024099586/ownership.xml","form_type":"4"}},{"id":1437656,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-08-08T17:39:21.000Z","date":"2024-07-26","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":1,"value":450000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to purchase 450,000 shares of common stock of Carmell Corporation were granted on July 26, 2024 and vest as follows: 25% vested on July 26, 2025 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes options to purchase 426,878 shares of common stock of Carmell Corporation that were granted on October 9, 2023 and vest as follows: 25% vest on October 9, 2024 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":876878,"derivative":{"exercise_price":1,"expiration_date":"2034-07-26","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0000950170-24-094223","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024094223/ownership.xml","form_type":"4"}},{"id":1437996,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86226,"kind":"person","name":"Bracken-Ferguson Kendra","position":1,"cik":"0002033273","reported_name":"Bracken-Ferguson Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-08-08T17:18:16.000Z","date":"2024-07-30","kind":"grant","planned":false,"acquired":true,"shares":908893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 908,893 shares of common stock of Carmell Corporation were granted on July 30, 2024 and vest as follows: 25% vested on July 30, 2025 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Options to purchase 908,893 shares of common stock of Carmell Corporation were granted on July 30, 2024 and vest as follows: 25% vested on July 30, 2025 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":908893,"derivative":{"exercise_price":1.11,"exercise_date":"2025-07-30","expiration_date":"2034-07-30","underlying":"Common Stock","underlying_shares":908893},"source":{"system":"sec-edgar","filing":"0000950170-24-094197","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033273/000095017024094197/ownership.xml","form_type":"4"}},{"id":1478639,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T08:21:24.000Z","date":"2021-09-23","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares beneficially owned by the Reporting Person include 54,455 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of June 12, 2024."}],"balance_after":54445,"source":{"system":"sec-edgar","filing":"0000950170-24-073349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017024073349/ownership.xml","form_type":"4"}},{"id":1478638,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T08:21:24.000Z","date":"2024-06-12","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.2046,"value":4409.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.1835 to $2.2257, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2"}],"balance_after":6400,"source":{"system":"sec-edgar","filing":"0000950170-24-073349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017024073349/ownership.xml","form_type":"4"}},{"id":1482347,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86225,"kind":"person","name":"Cassaday Bryan J.","position":1,"cik":"0002002588","reported_name":"Cassaday Bryan J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-12T07:59:30.000Z","date":"2024-06-10","kind":"purchase","planned":false,"acquired":true,"shares":440,"price":2.5,"value":1100.0,"ownership":{"direct":true},"balance_after":2775,"source":{"system":"sec-edgar","filing":"0000950170-24-072256","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2002588/000095017024072256/ownership.xml","form_type":"4"}},{"id":1484415,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-06-10T09:03:44.000Z","date":"2021-07-26","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By AHAC Sponsor III LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."}],"balance_after":4249908,"source":{"system":"sec-edgar","filing":"0000950170-24-071092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024071092/ownership.xml","form_type":"4"}},{"id":1484414,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-06-10T09:03:44.000Z","date":"2024-06-06","kind":"purchase","planned":false,"acquired":true,"shares":2100,"price":2.6317,"value":5526.57,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.58 to $2.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1."}],"balance_after":72103,"source":{"system":"sec-edgar","filing":"0000950170-24-071092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024071092/ownership.xml","form_type":"4"}},{"id":1484413,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-06-10T09:03:44.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.5,"value":5000.0,"ownership":{"direct":true},"balance_after":70003,"source":{"system":"sec-edgar","filing":"0000950170-24-071092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024071092/ownership.xml","form_type":"4"}},{"id":1484412,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-06-10T09:03:44.000Z","date":"2024-05-28","kind":"purchase","planned":false,"acquired":true,"shares":20,"price":2.57,"value":51.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.50 to $2.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":68003,"source":{"system":"sec-edgar","filing":"0000950170-24-071092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024071092/ownership.xml","form_type":"4"}},{"id":1496861,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86225,"kind":"person","name":"Cassaday Bryan J.","position":1,"cik":"0002002588","reported_name":"Cassaday Bryan J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T17:25:54.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":365,"price":2.55,"value":930.75,"ownership":{"direct":true},"balance_after":2335,"source":{"system":"sec-edgar","filing":"0000950170-24-067452","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2002588/000095017024067452/ownership.xml","form_type":"4"}},{"id":1496860,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86225,"kind":"person","name":"Cassaday Bryan J.","position":1,"cik":"0002002588","reported_name":"Cassaday Bryan J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T17:25:54.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":30,"price":2.6,"value":78.0,"ownership":{"direct":true},"balance_after":1970,"source":{"system":"sec-edgar","filing":"0000950170-24-067452","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2002588/000095017024067452/ownership.xml","form_type":"4"}},{"id":1499918,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-05-28T17:02:11.000Z","date":"2021-07-26","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By AHAC Sponsor III LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."}],"balance_after":4249908,"source":{"system":"sec-edgar","filing":"0000950170-24-065344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024065344/ownership.xml","form_type":"4"}},{"id":1499917,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-05-28T17:02:11.000Z","date":"2024-05-24","kind":"purchase","planned":false,"acquired":true,"shares":1939,"price":2.574,"value":4990.986,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.50 to $2.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":67983,"source":{"system":"sec-edgar","filing":"0000950170-24-065344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024065344/ownership.xml","form_type":"4"}},{"id":1499916,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-05-28T17:02:11.000Z","date":"2024-05-23","kind":"purchase","planned":false,"acquired":true,"shares":2100,"price":2.5,"value":5250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.42 to $2.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":66044,"source":{"system":"sec-edgar","filing":"0000950170-24-065344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024065344/ownership.xml","form_type":"4"}},{"id":1505010,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-05-22T17:13:26.000Z","date":"2021-07-26","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By AHAC Sponsor III LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."}],"balance_after":4249908,"source":{"system":"sec-edgar","filing":"0000950170-24-063592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024063592/ownership.xml","form_type":"4"}},{"id":1505009,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-05-22T17:13:26.000Z","date":"2024-05-22","kind":"purchase","planned":false,"acquired":true,"shares":4051,"price":2.412,"value":9771.012,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.35 to $2.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":63944,"source":{"system":"sec-edgar","filing":"0000950170-24-063592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024063592/ownership.xml","form_type":"4"}},{"id":1505008,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-05-22T17:13:26.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":1515,"price":2.387,"value":3616.305,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.33 to $2.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":59893,"source":{"system":"sec-edgar","filing":"0000950170-24-063592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024063592/ownership.xml","form_type":"4"}},{"id":1505007,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-05-22T17:13:26.000Z","date":"2024-05-20","kind":"purchase","planned":false,"acquired":true,"shares":1172,"price":2.219,"value":2600.668,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.18 to $2.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":58378,"source":{"system":"sec-edgar","filing":"0000950170-24-063592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024063592/ownership.xml","form_type":"4"}},{"id":1505006,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-05-22T17:10:54.000Z","date":"2021-07-26","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By AHAC Sponsor III LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."}],"balance_after":4249908,"source":{"system":"sec-edgar","filing":"0000950170-24-063586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024063586/ownership.xml","form_type":"4"}},{"id":1505005,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-05-22T17:10:54.000Z","date":"2024-04-04","kind":"purchase","planned":false,"acquired":true,"shares":8680,"price":2.88,"value":24998.4,"ownership":{"direct":true},"balance_after":57206,"source":{"system":"sec-edgar","filing":"0000950170-24-063586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024063586/ownership.xml","form_type":"4"}},{"id":1686870,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-01-04T21:17:09.000Z","date":"2021-07-26","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By AHAC Sponsor III LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."}],"balance_after":4249908,"source":{"system":"sec-edgar","filing":"0000950170-24-002269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024002269/ownership.xml","form_type":"4"}},{"id":1686869,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86212,"kind":"person","name":"Shukla Rajiv","position":1,"cik":"0001709033","reported_name":"Shukla Rajiv","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2024-01-04T21:17:09.000Z","date":"2023-01-02","kind":"grant","planned":false,"acquired":true,"shares":14347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The indicated shares were issued to the Reporting Person pursuant to the Executive Employment Agreement between the Issuer and the Reporting Person dated December 29, 2023.  Such agreement was included in the Issuer's Form 8-K filed on January 5, 2024."}],"balance_after":48526,"source":{"system":"sec-edgar","filing":"0000950170-24-002269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709033/000095017024002269/ownership.xml","form_type":"4"}},{"id":1705318,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86225,"kind":"person","name":"Cassaday Bryan J.","position":1,"cik":"0002002588","reported_name":"Cassaday Bryan J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-19T17:00:05.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":440,"price":3.5,"value":1540.0,"ownership":{"direct":true},"balance_after":1940,"source":{"system":"sec-edgar","filing":"0000950170-23-071562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2002588/000095017023071562/ownership.xml","form_type":"4"}},{"id":1707644,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86223,"kind":"person","name":"Spenlehauer Gilles","position":1,"cik":"0001997250","reported_name":"Spenlehauer Gilles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:13:12.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":591,"price":3.9351,"value":2325.6441,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.93 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5381,"source":{"system":"sec-edgar","filing":"0000950170-23-071167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1997250/000095017023071167/ownership.xml","form_type":"4"}},{"id":1707643,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86223,"kind":"person","name":"Spenlehauer Gilles","position":1,"cik":"0001997250","reported_name":"Spenlehauer Gilles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:13:12.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":313,"price":3.6119,"value":1130.5247,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.40 to $3.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":4790,"source":{"system":"sec-edgar","filing":"0000950170-23-071167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997250/000095017023071167/ownership.xml","form_type":"4"}},{"id":1707646,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86224,"kind":"person","name":"Frisch Scott M.","position":1,"cik":"0001997294","reported_name":"Frisch Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:12:55.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":591,"price":3.9351,"value":2325.6441,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.93 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5381,"source":{"system":"sec-edgar","filing":"0000950170-23-071166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1997294/000095017023071166/ownership.xml","form_type":"4"}},{"id":1707645,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86224,"kind":"person","name":"Frisch Scott M.","position":1,"cik":"0001997294","reported_name":"Frisch Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:12:55.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":313,"price":3.6119,"value":1130.5247,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.40 to $3.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":4790,"source":{"system":"sec-edgar","filing":"0000950170-23-071166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997294/000095017023071166/ownership.xml","form_type":"4"}},{"id":1706546,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:11:13.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":739,"price":3.9351,"value":2908.0389,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.93 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":6727,"source":{"system":"sec-edgar","filing":"0000950170-23-071164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017023071164/ownership.xml","form_type":"4"}},{"id":1706545,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:11:13.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":391,"price":3.6119,"value":1412.2529,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.40 to $3.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5988,"source":{"system":"sec-edgar","filing":"0000950170-23-071164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017023071164/ownership.xml","form_type":"4"}},{"id":1706584,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:10:44.000Z","date":"2021-09-23","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares beneficially owned by the Reporting Person include 48,734 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 18, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares beneficially owned by the Reporting Person include 48,734 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 18, 2023."}],"balance_after":74385,"source":{"system":"sec-edgar","filing":"0000950170-23-071163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017023071163/ownership.xml","form_type":"4"}},{"id":1706583,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:10:44.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":739,"price":3.9351,"value":2908.0389,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.93 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":6727,"source":{"system":"sec-edgar","filing":"0000950170-23-071163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017023071163/ownership.xml","form_type":"4"}},{"id":1706582,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:10:44.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":391,"price":3.6119,"value":1412.2529,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.40 to $3.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5988,"source":{"system":"sec-edgar","filing":"0000950170-23-071163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017023071163/ownership.xml","form_type":"4"}},{"id":1706826,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:10:43.000Z","date":"2021-09-23","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares beneficially owned by the Reporting Person include 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 18, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares beneficially owned by the Reporting Person include 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 18, 2023."}],"balance_after":63472,"source":{"system":"sec-edgar","filing":"0000950170-23-071162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023071162/ownership.xml","form_type":"4"}},{"id":1706825,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:10:43.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":739,"price":3.9351,"value":2908.0389,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.93 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":6727,"source":{"system":"sec-edgar","filing":"0000950170-23-071162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023071162/ownership.xml","form_type":"4"}},{"id":1706824,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:10:43.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":391,"price":3.6119,"value":1412.2529,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.40 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5988,"source":{"system":"sec-edgar","filing":"0000950170-23-071162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023071162/ownership.xml","form_type":"4"}},{"id":1712209,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:53:44.000Z","date":"2021-09-23","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares beneficially owned by the Reporting Person include 44,845 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 13, 2023."}],"balance_after":44845,"source":{"system":"sec-edgar","filing":"0000950170-23-070174","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017023070174/ownership.xml","form_type":"4"}},{"id":1712208,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:53:44.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":2400,"price":3.471,"value":8330.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.46 to $3.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2"}],"balance_after":4400,"source":{"system":"sec-edgar","filing":"0000950170-23-070174","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017023070174/ownership.xml","form_type":"4"}},{"id":1712207,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:53:44.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":3.5,"value":7000.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000950170-23-070174","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017023070174/ownership.xml","form_type":"4"}},{"id":1711989,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:48:50.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":5.5713,"value":6056.0031,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.47 to $3.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5597,"source":{"system":"sec-edgar","filing":"0000950170-23-070171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017023070171/ownership.xml","form_type":"4"}},{"id":1711988,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:48:50.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":3.5016,"value":3806.2392,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":4510,"source":{"system":"sec-edgar","filing":"0000950170-23-070171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017023070171/ownership.xml","form_type":"4"}},{"id":1711987,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86210,"kind":"person","name":"Sturgeon Patrick A","position":1,"cik":"0001822507","reported_name":"Sturgeon Patrick A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:48:50.000Z","date":"2023-12-11","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":3.5271,"value":3833.9577,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":3423,"source":{"system":"sec-edgar","filing":"0000950170-23-070171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822507/000095017023070171/ownership.xml","form_type":"4"}},{"id":1712824,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86224,"kind":"person","name":"Frisch Scott M.","position":1,"cik":"0001997294","reported_name":"Frisch Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:38:22.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":869,"price":5.5713,"value":4841.4597,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.47 to $3.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":4477,"source":{"system":"sec-edgar","filing":"0000950170-23-070169","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1997294/000095017023070169/ownership.xml","form_type":"4"}},{"id":1712823,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86224,"kind":"person","name":"Frisch Scott M.","position":1,"cik":"0001997294","reported_name":"Frisch Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:38:22.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":869,"price":3.5016,"value":3042.8904,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":3608,"source":{"system":"sec-edgar","filing":"0000950170-23-070169","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1997294/000095017023070169/ownership.xml","form_type":"4"}},{"id":1712822,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86224,"kind":"person","name":"Frisch Scott M.","position":1,"cik":"0001997294","reported_name":"Frisch Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:38:22.000Z","date":"2023-12-11","kind":"purchase","planned":false,"acquired":true,"shares":870,"price":3.5271,"value":3068.577,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":2739,"source":{"system":"sec-edgar","filing":"0000950170-23-070169","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997294/000095017023070169/ownership.xml","form_type":"4"}},{"id":1712821,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86223,"kind":"person","name":"Spenlehauer Gilles","position":1,"cik":"0001997250","reported_name":"Spenlehauer Gilles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:37:00.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":869,"price":5.5713,"value":4841.4597,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.47 to $3.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":4477,"source":{"system":"sec-edgar","filing":"0000950170-23-070167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1997250/000095017023070167/ownership.xml","form_type":"4"}},{"id":1712820,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86223,"kind":"person","name":"Spenlehauer Gilles","position":1,"cik":"0001997250","reported_name":"Spenlehauer Gilles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:37:00.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":869,"price":3.5016,"value":3042.8904,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":3608,"source":{"system":"sec-edgar","filing":"0000950170-23-070167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1997250/000095017023070167/ownership.xml","form_type":"4"}},{"id":1712819,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86223,"kind":"person","name":"Spenlehauer Gilles","position":1,"cik":"0001997250","reported_name":"Spenlehauer Gilles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:37:00.000Z","date":"2023-12-11","kind":"purchase","planned":false,"acquired":true,"shares":870,"price":3.5271,"value":3068.577,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":2739,"source":{"system":"sec-edgar","filing":"0000950170-23-070167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997250/000095017023070167/ownership.xml","form_type":"4"}},{"id":1712003,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:54.000Z","date":"2021-09-23","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares beneficially owned by the Reporting Person consist of 48,543 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 13, 2023."}],"balance_after":48543,"source":{"system":"sec-edgar","filing":"0000950170-23-070166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017023070166/ownership.xml","form_type":"4"}},{"id":1712002,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:54.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":5.5713,"value":6056.0031,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.47 to $3.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5597,"source":{"system":"sec-edgar","filing":"0000950170-23-070166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017023070166/ownership.xml","form_type":"4"}},{"id":1712001,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:54.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":3.5016,"value":3806.2392,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":4510,"source":{"system":"sec-edgar","filing":"0000950170-23-070166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017023070166/ownership.xml","form_type":"4"}},{"id":1712000,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86211,"kind":"person","name":"Gregory Kathryn","position":1,"cik":"0001768530","reported_name":"Gregory Kathryn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:54.000Z","date":"2023-12-11","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":3.5271,"value":3833.9577,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":3423,"source":{"system":"sec-edgar","filing":"0000950170-23-070166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768530/000095017023070166/ownership.xml","form_type":"4"}},{"id":1712243,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:20.000Z","date":"2021-09-23","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares beneficially owned by the Reporting Person consist of 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 13, 2023."}],"balance_after":63472,"source":{"system":"sec-edgar","filing":"0000950170-23-070165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023070165/ownership.xml","form_type":"4"}},{"id":1712242,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:20.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":5.5713,"value":6056.0031,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.47 to $3.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5597,"source":{"system":"sec-edgar","filing":"0000950170-23-070165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023070165/ownership.xml","form_type":"4"}},{"id":1712241,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:20.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":3.5016,"value":3806.2392,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":4510,"source":{"system":"sec-edgar","filing":"0000950170-23-070165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023070165/ownership.xml","form_type":"4"}},{"id":1712240,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:20.000Z","date":"2023-12-11","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":3.5271,"value":3833.9577,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":3423,"source":{"system":"sec-edgar","filing":"0000950170-23-070165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023070165/ownership.xml","form_type":"4"}},{"id":1717636,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T21:19:31.000Z","date":"2023-12-08","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares beneficially owned by the Reporting Person consist of 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 8, 2023."}],"balance_after":63472,"source":{"system":"sec-edgar","filing":"0000950170-23-069165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023069165/ownership.xml","form_type":"4"}},{"id":1717635,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T21:19:31.000Z","date":"2023-12-08","kind":"purchase","planned":false,"acquired":true,"shares":46,"price":3.15,"value":144.9,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":2336,"source":{"system":"sec-edgar","filing":"0000950170-23-069165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023069165/ownership.xml","form_type":"4"}},{"id":1717634,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T21:19:31.000Z","date":"2023-12-07","kind":"purchase","planned":false,"acquired":true,"shares":248,"price":3.0658,"value":760.3184,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.01 to $3.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":2290,"source":{"system":"sec-edgar","filing":"0000950170-23-069165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023069165/ownership.xml","form_type":"4"}},{"id":1717633,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T21:19:31.000Z","date":"2023-12-06","kind":"purchase","planned":false,"acquired":true,"shares":608,"price":3.0329,"value":1844.0032,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.99 to $3.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":2042,"source":{"system":"sec-edgar","filing":"0000950170-23-069165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023069165/ownership.xml","form_type":"4"}}],"next_cursor":"2023-12-08T21:19:31.000000Z,1717633"}